Study: Molecule targets could lead to new UTI drugs

02/23/2009 | Yahoo!

U.S. researchers have identified two molecular targets, which could aid in the development of a new antibiotic for urinary tract infections, that target pathogenic E. coli strains without harming beneficial bacteria in the digestive system.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA